Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Iain MacPhee

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Expert Opinion on Drug Safety|September 15, 2015
Do statins prevent acute kidney injury?Barbara Philips, Iain MacPhee
Nephron. Clinical Practice|March 26, 2014
UK Renal Registry 16th annual report: chapter 3 demographic and biochemistry profile of kidney transplant recipients in the UK in 2012: national and centre-specific analysesRishi Pruthi, Anna Casula, Iain Macphee
Expert Opinion on Drug Metabolism & Toxicology|April 21, 2010
Using drug probes to monitor hepatic drug metabolism in critically ill patients: midazolam, a flawed but useful tool for clinical investigation of CYP3A activity?Chris Kirwan, Iain MacPhee, Barbara Philips
Nephron|February 20, 2015
UK Renal Registry 17th Annual Report: Chapter 3 Demographic and Biochemistry Profile of Kidney Transplant Recipients in the UK in 2013: National and Centre-specific AnalysesRishi Pruthi, Anna Casula, Iain MacPhee
Nephron. Clinical Practice|June 19, 2013
UK Renal Registry 15th annual report: Chapter 3 demographic and biochemistry profile of kidney transplant recipients in the UK in 2011: national and centre-specific analysesRishi Pruthi, Anna Casula, Iain MacPhee
Nephron|April 27, 2016
UK Renal Registry 18th Annual Report: Chapter 3 Demographic and Biochemistry Profile of Kidney Transplant Recipients in the UK in 2014: National and Centre-specific AnalysesRishi Pruthi, Anna Casula, Iain MacPhee
International Journal of Molecular Sciences|February 18, 2014
Xenobiotic metabolism: the effect of acute kidney injury on non-renal drug clearance and hepatic drug metabolismJohn Dixon, Katie Lane, Iain Macphee, et al.
Nephron. Clinical Practice|September 12, 2012
Chapter 3 Demographic and biochemistry profile of kidney transplant recipients in the UK in 2010: national and centre-specific analysesIain MacPhee, Lynsey Webb, Anna Casula, et al.
Expert Opinion on Drug Metabolism & Toxicology|October 1, 2013
The effects of acute renal failure on drug metabolismBarbara J Philips, Katie Lane, John Dixon, et al.
Clinical and Translational Science|November 15, 2021
Limited sampling strategies for estimation of tacrolimus exposure in kidney transplant recipients receiving extended-release tacrolimus preparationToqa El-Nahhas, Joyce Popoola, Iain MacPhee, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Expert Opinion on Drug Safety|September 15, 2015
Do statins prevent acute kidney injury?Barbara Philips, Iain MacPhee
Nephron. Clinical Practice|March 26, 2014
UK Renal Registry 16th annual report: chapter 3 demographic and biochemistry profile of kidney transplant recipients in the UK in 2012: national and centre-specific analysesRishi Pruthi, Anna Casula, Iain Macphee
Expert Opinion on Drug Metabolism & Toxicology|April 21, 2010
Using drug probes to monitor hepatic drug metabolism in critically ill patients: midazolam, a flawed but useful tool for clinical investigation of CYP3A activity?Chris Kirwan, Iain MacPhee, Barbara Philips
Nephron|February 20, 2015
UK Renal Registry 17th Annual Report: Chapter 3 Demographic and Biochemistry Profile of Kidney Transplant Recipients in the UK in 2013: National and Centre-specific AnalysesRishi Pruthi, Anna Casula, Iain MacPhee
Nephron. Clinical Practice|June 19, 2013
UK Renal Registry 15th annual report: Chapter 3 demographic and biochemistry profile of kidney transplant recipients in the UK in 2011: national and centre-specific analysesRishi Pruthi, Anna Casula, Iain MacPhee
Nephron|April 27, 2016
UK Renal Registry 18th Annual Report: Chapter 3 Demographic and Biochemistry Profile of Kidney Transplant Recipients in the UK in 2014: National and Centre-specific AnalysesRishi Pruthi, Anna Casula, Iain MacPhee
International Journal of Molecular Sciences|February 18, 2014
Xenobiotic metabolism: the effect of acute kidney injury on non-renal drug clearance and hepatic drug metabolismJohn Dixon, Katie Lane, Iain Macphee, et al.
Nephron. Clinical Practice|September 12, 2012
Chapter 3 Demographic and biochemistry profile of kidney transplant recipients in the UK in 2010: national and centre-specific analysesIain MacPhee, Lynsey Webb, Anna Casula, et al.
Expert Opinion on Drug Metabolism & Toxicology|October 1, 2013
The effects of acute renal failure on drug metabolismBarbara J Philips, Katie Lane, John Dixon, et al.
Clinical and Translational Science|November 15, 2021
Limited sampling strategies for estimation of tacrolimus exposure in kidney transplant recipients receiving extended-release tacrolimus preparationToqa El-Nahhas, Joyce Popoola, Iain MacPhee, et al.
Pageof 2